# FDA recall D-1488-2020

> **Vilvet Pharmaceuticals Inc.** · Class II · drug recall initiated 2020-07-24.

## Product

VILEVEV MB Urinary Antispetic (81.0 mg methenamine, 40.8 mg sodium phosphate monobasic and 10.8 mg methylene blue, 0.12 mg hyoscyamine sulfate and 32.4 mg phenyl salicylate), Rx Only, 90 Tablets per Bottle, Manufactured for: Vilvet Pharmaceuticals, Inc., Chester Springs, PA 19425, NDC 71186-000-24.

## Reason for recall

cGMP deviations

## Distribution

Nationwide within the US

## Key facts

- **Recall number:** D-1488-2020
- **Recalling firm:** Vilvet Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-07-24
- **Report date:** 2020-08-12
- **Termination date:** 2022-01-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Chester Springs, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1488-2020

## Citation

> AI Analytics. FDA recall D-1488-2020. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1488-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*